Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CRMD
#2460
CorMedix Inc.
7.130
0
-1.79%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
-1.79%
Monthly Change
-8.24%
6 month change
-36.90%
Year Change
-36.90%
Previous Close
7.260
0
Open
7.130
0
Bid
Ask
Low
7.130
0
High
7.130
0
Volume
99
Markets
US Stock Market
Healthcare
CRMD
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
60.68 M
65.18 M
67.82 M
74.65 M
78.79 M
—
Valuation ratios
Enterprise value
454.99 M
487.32 M
351.51 M
760.37 M
867.82 M
2.47 B
Price to earnings ratio
-10.1
-27
24.64
15.79
5.56
19
Price to sales ratio
38.71
10.97
4.72
6.68
4.07
26.44
Price to cash flow ratio
-8.18
-9.42
-21.6
32.79
12.04
13.81
Price to book ratio
1.93
5.63
1.26
1.72
1.11
9.71
Enterprise value to EBITDA ratio
-8.97
-22.1
23.39
15.2
7.75
24.24
Profitability ratios
Return on assets %
-0.04
0.11
0.14
0.08
0.14
0.47
Return on equity %
-0.05
0.16
0.18
0.09
0.29
0.72
Return on invested capital %
-146.64
221.48
225.66
223.32
142.32
812.79
Gross margin %
94.01
96.23
95.91
95.31
89.26
376.73
Operating margin %
-28.7
41.45
51.5
49.18
49.24
191.37
EBITDA margin %
-27.57
42.04
51.91
49.72
56.45
200.13
Net margin %
-24.24
43.14
52.82
49.9
104.11
249.97
Liquidity ratios
Quick ratio
3.6
3.16
3.99
7.52
1.73
16.4
Current ratio
3.96
3.39
4.21
7.82
1.94
17.36
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.17
0.32
0.29
0.2
0.21
1.01
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
0.39
—
Long term debt to total equity ratio
—
—
—
—
0.79
—
Per share metrics
Operating cash flow per share
-0.23
-0.1
0.29
0.42
0.36
0.97
EBIT per share
-0.06
0.22
0.29
0.27
0.64
1.42
EBITDA per share
-0.05
0.22
0.29
0.27
0.68
1.47
Total debt per share
—
—
—
—
—
—
Cash per share
0.78
0.88
1.12
2.65
0.65
5.3
Net current asset value per share
1.24
1.95
2.1
3.45
3.01
10.51
Tangible book value per share
0.97
1.41
1.64
3.04
-0.39
5.7
Working capital per share
0.93
1.37
1.6
3.01
1.46
7.44
Book value per share
1
1.44
1.67
3.07
4.34
10.51
News
Cytek Biosciences, Inc. (CTKB) Reports Q4 Loss, Tops Revenue Estimates
CRMD vs. TBPH: Which Small-Cap Biotech Stock Is the Better Bet?
Should Investors Buy, Sell or Hold CRMD Stock Ahead of Q4 Earnings?
CorMedix Down 27% in 3 Months: Is It Time to Sell the Stock?
CorMedix Inc. (CRMD) Analyst/Investor Day Transcript
CorMedix Inc. (CRMD) Analyst/Investor Day - Slideshow (NASDAQ:CRMD) 2026-02-11
CorMedix Banks on DefenCath Sales in Q4 as Melinta Adds Upside
CorMedix stock rises after announcing $75 million share buyback plan
CorMedix announces $75 million share repurchase program
CRMD Down 31% in a Month: Is This an Indication to Sell the Stock?
Will CRMD'S Bearish 2026 View Impact DefenCath's Long-Term Adoption?
CorMedix stock price target lowered to $13 at H.C. Wainwright